Literature DB >> 2409148

The T cell response to the glycoprotein D of the herpes simplex virus: the significance of antigen conformation.

E Heber-Katz, M Hollosi, B Dietzschold, F Hudecz, G D Fasman.   

Abstract

Synthetic peptides corresponding to the first 23 amino acids of the glycoprotein D molecule of herpes simplex virus have been used to immunize mice and examine the role of antigen conformation in T cell responses. The structure of the peptides was determined by circular dichroism studies and was shown to be consistent with theoretical structure predictions. T cell clones were found that could respond to peptides that were nonhelical, and this response, which was directed to the C-terminal determinant (residues 8-23), could be modified by a constrained N-terminal sequence (residues 1-7) of the peptide. Namely, substitution of Ala for Pro at position 7 induced an alpha-helix and inhibited the response. Furthermore, a response to the N-terminal part of the molecule seemed to be directed to the alpha-helix and correlated positively with calculated degree of helicity. This response was also modified, in this case, by the C-terminal part of the molecule. These results suggest that local secondary structure of an antigen may regulate T cell responses and that structural changes in the peptide antigen downstream from the determinant modify recognition of that determinant. Furthermore, antigen processing by the macrophage and antigen presentation of T cells appears to conserve antigen structural integrity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409148

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Production of a recombinant monoclonal antibody to Herpes Simplex Virus glycoprotein D for immunoaffinity purification of tagged proteins.

Authors:  Sara M O'Rourke; Bin Yu; Javier F Morales; Chelsea M Didinger; David L Alexander; Christopher Vollmers; Phillip W Berman
Journal:  J Immunol Methods       Date:  2018-11-28       Impact factor: 2.303

2.  Mapping major and minor T-cell epitopes in vitro and their immunogenic or tolerogenic effect in vivo in non-human primates.

Authors:  P R Walker; R Smerdon; J Haron; T Lehner
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

3.  Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus.

Authors:  R A Ffrench; X L Tang; E M Anders; D C Jackson; D O White; H Drummer; J D Wade; G W Tregear; L E Brown
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutants.

Authors:  M I Muggeridge; V J Isola; R A Byrn; T J Tucker; A C Minson; J C Glorioso; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

5.  Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations.

Authors:  P Ljungman; L Zetterqvist; V A Sundqvist; S Jeansson; A Heimdahl; B Wahren
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

6.  Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.

Authors:  V J Isola; R J Eisenberg; G R Siebert; C J Heilman; W C Wilcox; G H Cohen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.

Authors:  J W Torseth; G H Cohen; R J Eisenberg; P W Berman; L A Lasky; C P Cerini; C J Heilman; S Kerwar; T C Merigan
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

8.  Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccines.

Authors:  K Brynestad; B Babbit; L Huang; B T Rouse
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

9.  Liposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice.

Authors:  K Olson; P Macias; S Hutton; W A Ernst; G Fujii; J P Adler-Moore
Journal:  Vaccine       Date:  2009-10-14       Impact factor: 3.641

10.  Helper T cells induced by a purified 28-kilodalton antigen of Schistosoma mansoni protect rats against infection.

Authors:  C Auriault; J M Balloul; R J Pierce; M Damonneville; P Sondermeijer; A Capron
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.